|
2025
|
Invention
|
Modified amino acids.
Provided herein are modified amino acids comprising an azido group, polype... |
|
|
P/S
|
Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in... |
|
2024
|
Invention
|
Overexpression of lysozyme in t7 rna polymerase-expressing host cells. Disclosed herein are host ... |
|
|
Invention
|
Anti-tissue factor antibodies and antibody conjugates, compositions comprising anti-tissue factor... |
|
|
Invention
|
Dual payload antibody drug conjugates. The present disclosure is related to dual payload antibody... |
|
|
Invention
|
Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods... |
|
|
P/S
|
Pharmaceutical and biological preparations for the immune system targeting immuno-oncology pathwa... |
|
|
Invention
|
Sting agonist compounds and conjugates.
The present disclosure is related to STING agonists, lin... |
|
|
Invention
|
Sting agonist compounds and conjugates. The present disclosure is related to STING agonists, link... |
|
|
Invention
|
Anti-folate receptor alpha antibody conjugates and their uses.
The present disclosure relates to... |
|
|
Invention
|
Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and meth... |
|
|
Invention
|
Anti-bcma antibodies and treatment methods.
The present disclosure relates to antibodies that se... |
|
|
Invention
|
E. coli strains. E. coliE. coliE. coliE. coli cells comprise an RF2 variant that has greater acti... |
|
2023
|
Invention
|
Hemiasterlin derivatives for conjugation and therapy.
Provided herein are hemiasterlin derivativ... |
|
|
Invention
|
Interferon alpha polypeptides and conjugates. The present disclosure generally relates to interfe... |
|
|
Invention
|
Anti-folate receptor conjugate therapy for cancer treatment.
The present disclosure relates to t... |
|
|
Invention
|
Anti-cd3 antibodies, compositions comprising anti-cd3 antibodies and methods of making and using ... |
|
|
Invention
|
Interleukin-18 variants and uses thereof. The present disclosure provides IL-18 polypeptides with... |
|
|
Invention
|
Spray dried extract. This disclosure provides for an improved method of stabilizing spray-dried b... |
|
|
Invention
|
Spray dried extract.
This disclosure provides for an improved method of stabilizing spray-dried ... |
|
|
Invention
|
Anti-cd74 antibody conjugates, compositions comprising anti cd74 antibody conjugates and methods ... |
|
|
Invention
|
Antibodies with engineered ch2 domains, compositions thereof and methods of using the same.
The ... |
|
|
Invention
|
Protease/enzyme cleavable linker-payloads and protein conjugates. Provided herein are compounds, ... |
|
|
Invention
|
Anti-ror1 antibodies and antibody conjugates, compositions comprising anti-ror1 antibodies or ant... |
|
|
Invention
|
Il-12 mutants with reduced toxicity, compositions thereof and methods of using the same. The pres... |
|
|
Invention
|
Beta-glucuronide linker-payloads, protein conjugates thereof, and methods thereof.
Provided here... |
|
|
Invention
|
Β-glucuronide linker-payloads, protein conjugates thereof, and methods thereof. Provided herein a... |
|
|
Invention
|
Sting agonist compounds. The present disclosure is related to STING agonists, pharmaceutical comp... |
|
|
Invention
|
Immunomodulator antibody drug conjugates and uses thereof.
Provided herein are compounds, trifun... |
|
2022
|
Invention
|
Modified amino acids. Provided herein are modified amino acids comprising an azido group, polypep... |
|
|
Invention
|
Anti-folate receptor conjugate cancer therapy.
The present disclosure relates to therapies with ... |
|
|
Invention
|
Anti-folate receptor conjugate cancer therapy. The present disclosure relates to therapies with a... |
|
|
Invention
|
Formulations for drying bacterial cell extracts. This invention provides for an improved method o... |
|
|
Invention
|
E. coli strains having an oxidative cytoplasm. E. coli strain has an oxidative cytosol and can be... |
|
|
Invention
|
Anti-folate receptor conjugate combination therapy with bevacizumab.
The present disclosure rela... |
|
|
Invention
|
Anti-folate receptor conjugate combination therapy with bevacizumab. The present disclosure relat... |
|
|
Invention
|
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their pr... |
|
2021
|
Invention
|
Fluorenylmethyloxycarbonyl and fluorenylmethylaminocarbonyl compounds, protein conjugates thereof... |
|
|
Invention
|
Method for large scale production of antibodies using a cell-free protein synthesis system.
Desc... |
|
|
Invention
|
Method for large scale production of antibodies using a cell-free protein synthesis system. Descr... |
|
|
Invention
|
Anti-epcam antibodies, compositions comprising anti-epcam antibodies and methods of making and us... |
|
|
Invention
|
Antibodies with engineered ch2 domains, compositions thereof and methods of using the same. The p... |
|
|
Invention
|
Method of fast comparison of molecular shapes. An open-source fast non-alignment-based method of ... |
|
|
Invention
|
Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of t... |
|
2020
|
P/S
|
Bacterial extract preparations for the cell free production of therapeutic proteins or peptides f... |
|
|
P/S
|
Bacterial lysate preparations for the cell free production of therapeutic proteins or peptides fo... |
|
|
Invention
|
1-(4-(aminomethyl)benzyl)-2-butyl-2h-pyrazolo[3,4-c]quinolin-4-amine derivatives and related comp... |
|
|
Invention
|
5h-pyrrolo[3,2-d]pyrimidine-2,4-diamino compounds and antibody conjugates thereof.
The present d... |
|
|
Invention
|
Anti-bcma antibody conjugates.
The present disclosure relates to antibody conjugates with bindin... |
|
2019
|
Invention
|
Combination therapies with anti-folate receptor antibody conjugates.
The present disclosure rela... |
|
2018
|
P/S
|
Manufacture of pharmaceutical preparations for others Pharmaceutical preparations, namely, protei... |
|
2013
|
P/S
|
Customized manufacture of therapeutic proteins for the treatment or prevention of diseases by pha... |
